Based on data from the past 90 days ending January 09, 2026, Entrada Therapeutics's three largest insider shareholders are TenPercentOwner Bros. Advisors Lp Baker (4.69Mn shares), Director Todd Foley (4.43Mn shares), TenPercentOwner Bioventures 2014, L.P. Mpm (4.38Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Bros. Advisors Lp Baker | 4,691,392 | 24 Nov, 2025 | |
| Todd Foley | 4,425,784 | 04 Nov, 2021 | |
| Bioventures 2018, L.P. Mpm | 4,381,062 | 12 Dec, 2024 | |
| Bioventures 2014, L.P. Mpm | 4,381,062 | 12 Dec, 2024 | |
| Ventures V, L.P. 5am | 4,056,379 | 18 Nov, 2025 | |
| Kush Parmar | 2,963,066 | 18 Nov, 2025 | |
| Holding Ltd Roche | 2,813,525 | 04 Nov, 2021 | |
| Group, Llc Redmile | 1,954,420 | 04 Nov, 2021 | |
| Dipal Doshi | Ceo | 415,664 | 04 Sep, 2025 |
| Natarajan Sethuraman | President And Research & Develop. | 197,899 | 04 Sep, 2025 |
| Nathan J Dowden | President & Coo | 179,059 | 04 Sep, 2025 |
| Kory James Wentworth | Chief Financial Officer | 110,026 | 24 Nov, 2025 |
| Peter S Kim | 104,330 | 05 Jun, 2024 | |
| Nerissa Kreher | Chief Medical Officer | 40,037 | 06 Sep, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 21 Nov, 2025 | Kory James Wentworth | Common Stock | D | 8,910 | $9.98 | 110,026 | D | S |
| 20 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 1,213 | $9.07 | 380,152 | I | P |
| 20 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 13,386 | $9.07 | 4,678,310 | I | P |
| 20 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 13,082 | $9.07 | 4,691,392 | I | P |
| 20 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 1,186 | $9.07 | 381,338 | I | P |
| 14 Nov, 2025 | Kush Parmar | Common Stock | D | 200,000 | $8.80 | 2,963,066 | I | S |
| 14 Nov, 2025 | Ventures V, L.P. 5am | Common Stock | D | 200,000 | $8.80 | 2,963,066 | D | S |
| 12 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 80,881 | $7.73 | 4,653,430 | I | P |
| 12 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 11,494 | $7.95 | 4,664,924 | I | P |
| 12 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 1,040 | $7.95 | 378,939 | I | P |
| 12 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 7,321 | $7.73 | 377,899 | I | P |
| 11 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 30,879 | $7.54 | 4,572,549 | I | P |
| 11 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 11,701 | $7.39 | 4,541,670 | I | P |
| 11 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 1,059 | $7.39 | 367,783 | I | P |
| 11 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 2,795 | $7.54 | 370,578 | I | P |
| 10 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 267 | $7.22 | 366,724 | I | P |
| 10 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 2,947 | $7.22 | 4,529,969 | I | P |
| 10 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 2,296 | $7.21 | 366,457 | I | P |
| 10 Nov, 2025 | Bros. Advisors Lp Baker | Common Stock | A | 25,364 | $7.21 | 4,527,022 | I | P |
| 02 Sep, 2025 | Dipal Doshi | Common Stock | D | 8,723 | $5.43 | 415,664 | D | F |